Nemec Sarah bought BOLT
December 12, 2025 · Form 4 insider transaction
Nemec Sarah bought 1,589 shares of Bolt Biotherapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,589
Price
N/A
Total value
N/A
InsiderNemec Sarah
RoleOfficer
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 12, 2025
Filing dateDecember 16, 2025
Shares owned after1,589
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price.; For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024.